Advertisement

hautnah dermatologie

, Volume 34, Issue 5, pp 36–39 | Cite as

Chronisch-entzündliche Hauterkrankung

Kutaner Lupus erythematodes: eine Krankheit, viele Ausprägungsformen

  • Margitta Worm
Fortbildung
  • 75 Downloads

Aufgrund seiner vielen verschiedenen Ausprägungsformen ist der Lupus erythematodes nicht immer leicht zu diagnostizieren. Doch auch bei der Therapie der chronisch-entzündlichen Hauterkrankung gibt es Hürden und Risiken.

Literatur

  1. 1.
    Gilliam JN. The cutaneous signs of lupus erythematosus. Cont Educ Fam Phys 1977; 6: 34–70Google Scholar
  2. 2.
    Millard TP. Molecular Genetic of Cutaneous Lupus Erythematosus. In: Kuhn et al. Cutaneous Lupus Erythematosus. Berlin, Springer-Verlag, 2004: 205–11Google Scholar
  3. 3.
    Sontheimer RD. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev 2005; 4: 253–63CrossRefGoogle Scholar
  4. 4.
    Kuhn A et al. Lupus erythematosus tumidus — a neglected subset of cutaneous Lupus erythematosus: report of 40 cases. Arch Dermatol 2000;136:1033–41CrossRefGoogle Scholar
  5. 5.
    Tebbe B et al. Epidemiology and socioeconomic impact of skin disease in lupus erythematosus. Lupus 1997; 6: 96–104CrossRefGoogle Scholar
  6. 6.
    Kuhn A et al. Phototesting in lupus erythematosus: a 15-year experience. J Am Acad Dermatol 2001; 45: 86–95CrossRefGoogle Scholar
  7. 7.
    Boeckler P et al. The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2/C4 deficiency. Br J Dermatol 2005; 152: 265–70CrossRefGoogle Scholar
  8. 8.
    Artuz F et al. Efficacy of sulfasalazine in discoid lupus erythematosus. Int J Dermatol 1996; 35: 746–8CrossRefGoogle Scholar
  9. 9.
    Yoshimasu T et al. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT). Eur J Dermatol 2001; 11: 54–7PubMedPubMedCentralGoogle Scholar
  10. 10.
    Kuhn A et al. Kutaner LE. 2013; AWMF Nr. 013/060Google Scholar
  11. 11.
    Meier CR et al. Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 1998; 25: 1515–9PubMedPubMedCentralGoogle Scholar
  12. 12.
    Hampton PJ et al. Implication for photosensitive patients of ultraviolet A exposure in vehicles. Br J Dermatol 2004; 151: 873–6CrossRefGoogle Scholar
  13. 13.
    Johnson JA et al. Broad-spectrum photoprotection: the roles of tinted auto windows, sunscreens and browning agents in the diagnosis and treatment of photosensitivity. Dermatology 1992; 185: 237–41CrossRefGoogle Scholar
  14. 14.
    Tzung TY et al. Tacrolimus vs. clobetasol propionate in the treatment of facial cutaneous lupus erythematosus: a randomized, double-blind, bilateral comparison study. Br J Dermatol 2007; 156: 191–2CrossRefGoogle Scholar
  15. 15.
    Ochsendorf FR et al. Chloroquine retinopathy: avoidable by individualized daily dosing. Dtsch Med Wochenschr 1993; 118: 1895–8CrossRefGoogle Scholar
  16. 16.
    Pelle MT et al. Adverse cutaneous reactions to hydroxychloroquine are more common in patients with dermatomyositis than in patients with cutaneous lupus erythematosus. Arch Dermatol 2002; 138: 1231–3PubMedPubMedCentralGoogle Scholar
  17. 17.
    Pisoni CN et al. Mycophenolate mofetil in systemic lupus erythematosus: efficacy and tolerability in 86 patients. J Rheumatol 2005; 32: 1047–52PubMedPubMedCentralGoogle Scholar
  18. 18.
    Wallace DJ et al. Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet 2018; 392: 222–31CrossRefGoogle Scholar
  19. 19.
    Heine G, Lahl A, Müller C, Worm M. Vitamin D deficiency in patients with cutaneous lupus erythematosus is prevalent throughout the year. Br J Dermatol 2010; 163: 863–5CrossRefGoogle Scholar

Copyright information

© Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2018

Authors and Affiliations

  1. 1.Klinik für Dermatologie, Venerologie und AllergologieCharité— Universitätsmedizin BerlinBerlinDeutschland

Personalised recommendations